Dr. Muhammad Raza, MD

Dr. Raza practices at Deborah Heart and Lung Center in Browns Mills, New Jersey, part of Deborah Heart and Lung Center.

Dr. Raza's NPI, 1629308150, was assigned on January 6, 2010. Dr. Raza holds Pennsylvania license MD439617.

Dr. Raza's primary practice is Deborah Heart and Lung Center, at 200 Trenton Road, Browns Mills, NJ 08015 in Burlington County. The practice phone is (609) 893-6611.

Dr. Raza's primary practice is Deborah Heart and Lung Center in Browns Mills, New Jersey, part of Deborah Heart and Lung Center. Dr. Raza is also affiliated with Capital Health Medical Center - Hopewell. The medical group on file is Deborah Heart and Lung Center. Dmand AI also links Dr. Raza to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raza practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Raza's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Raza is licensed in Pennsylvania.

CMS data shows 503 Medicare services from Dr. Raza across 14 procedure codes in 2024, for 253 Medicare patients. Medicare paid $91,556 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 253 Medicare patients who saw Dr. Raza in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raza's median patient age at 74, with 40% women.

In 2024, Dr. Raza wrote 72 Medicare Part D claims for 14 patients. 94% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $56 in total drug cost. In 2023, CMS named 333 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Raza for performance year 2024, reported as part of a group. Dr. Raza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 66 procedures of coronary angioplasty and stenting by Dr. Raza, more than 90% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Raza, published from 2021 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Rectal Neoplasms and Robotic Surgical Procedures. Dr. Raza has published most often in Surgeon.

CMS Open Payments shows 474 general payments to Dr. Raza from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Janssen Pharmaceuticals, Inc paid the most, $43,379.